For research use only. Not for therapeutic Use.
Verazide(CAT: I038006) is a combination medication composed of hydrochlorothiazide and verapamil, primarily used for managing hypertension (high blood pressure). Hydrochlorothiazide is a thiazide diuretic that reduces blood pressure by promoting sodium and water excretion, decreasing blood volume. Verapamil is a calcium channel blocker that relaxes blood vessels and lowers heart rate, further aiding in blood pressure reduction. This dual mechanism effectively controls hypertension and reduces the risk of cardiovascular complications. Verazide is significant in cardiovascular research, particularly for developing advanced treatments targeting blood pressure regulation and heart health.
Catalog Number | I038006 |
CAS Number | 93-47-0 |
Synonyms | Verazide; Nicotazide; NSC180261; NSC-180261; NSC 180261 |
Molecular Formula | C15H15N3O3 |
Purity | 98% |
Solubility | To be determined |
Appearance | Solid powder |
Storage | Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years). |
IUPAC Name | N-[(Z)-(3,4-dimethoxyphenyl)methylideneamino]pyridine-4-carboxamide |
InChI | InChI=1S/C15H15N3O3/c1-20-13-4-3-11(9-14(13)21-2)10-17-18-15(19)12-5-7-16-8-6-12/h3-10H,1-2H3,(H,18,19)/b17-10+ |
InChIKey | HPXIKMBHOXLFOR-LICLKQGHSA-N |
SMILES | COC1=C(C=C(C=C1)/C=N\NC(=O)C2=CC=NC=C2)OC |